My new investments in psychedelic companies
In 2015 I wrote about buying $WEED stock and deduced that the marijuana industry was going to the moon. $WEED is up 800% since then. 🙂 Today I believe investing in psychedelics may be the next smart move. The industry is still small – worth about $3 billion this year. But reports say it could be worth $6.8 billion by 2027.
I first heard famous author Tim Ferris speak about psilocybin mushrooms and the medicinal applications they can have. If you’re normally a dull person, mushrooms can turn you into a fungi. 😅 So I decided to learn more about this niche market and ultimately began to invest in it.
In today’s post I’ll disclose which stocks I’ve bought since the start of the year, with a focus on psychedelic companies.
How to invest in psychedelic stocks
The easiest way to purchase a diversified basket of psychedelic stocks is through the Horizons Psychedelic Stock Index ETF (PSYK). But the management fee is 0.85%, which is kind of high. So I built my own basket of psychedelic stocks instead. 😉 Here they are.
- COMPASS pathways PLC. (CMPS – Nasdaq.)
I bought 10 shares in February at $41.50/share ($415 total.)
Founded in 2016 in the U.K. this is a medical care company that develops psilocybin formulas to treat patients with depression. Moreover, with a $1.2 billion market cap it makes up about 40% of the entire publicly traded psychedelics market.
- Catalyst Pharmaceuticals Enterprise (CPRX – Nasdaq.)
I bought 100 shares in March at $3.88/share ($388 total.)
This biopharmaceutical company has 3 drugs in development. It has a cheap P/E ratio of just 6.3x. The 12 month target price of this stock is $7.50. So that’s about 2x from today’s price. A lot will depend on how future clinical trials go. But it has potential.
- Numinus Wellness Inc (NUMI – TSX.)
I bought 300 shares in March at $1.18/share (354 total.)
Canadian based health care company providing psychedelic therapies. It has the license to test, buy, and sell MDMA, psilocybin, psilocin, DMT, and mescaline. It’s a micro cap stock at just $190 million.
- Mind Medicine Inc (MMED)
I bought 100 shares in March at $3.58/share (358 total.)
This is a leading clinical-stage psychedelic medicine biotech company. It has plenty of cash, about $200 million CAD, to support its drug development pipeline and tech platform.
- Cybin Inc (CYBN)
I bought 50 shares on April 6th at $1.65/share (82.50 total.)
Based out of Toronto, Cybin develops psychedelic pharmaceutical and non-psychedelic nutraceutical-based products, including medicinal mushroom products. 🍄
High risk – high reward
The best time to get into a new industry is during it’s nascent stage. But investing in psychedelics is highly speculative right now. There’s a chance I could lose all my money in all of these companies. I’m lucky enough to be in a position where I can make risky bets like this, but these stocks aren’t suitable for everyone. 🙂
If you do decide to invest in psychedelic stocks, make sure to limit your risk by controlling the position sizing so they don’t take up too mushroom in your portfolio. 😬
Right now technology is driving the healthcare industry to discover better medical solutions. New drugs are able to reach a group of patients with anxiety and depression that never had an opportunity to be treated before. 🙂 Times change. However, people don’t. When it comes to human behavior I have learned to bet on innovation.
I plan to buy more of these psychedelic focused companies during future market dips and corrections. 🙂
Other stocks I’ve bought
Additionally I have been purchasing other types of stocks as well listed below.
Currency works (CWRK) TSX
bought 50 shares at 2.80/share.
DMG blockchain solutions (DMGI NYSE)
bought 120 at 2.63/share.
Lundin Mining Corp (LUN TSX)
bought 50 shares at 14.55/share.
Open Text Corp (OTEX TSX)
bought 20 at 56.87/share.
Supreme Cannabis Co Inc (FIRE TSX)
Bought 500 shares at 0.33/share.
Autodesk Inc (ADSK)
Bought 3 shares at $269.15/share.
AbbVie Inc (ABBV)
Bought 5 shares at $104.31/share.
Bristol Meyers Squibb (BMY)
Bought 10 shares at $62.30/share.
Domino’s Pizza Inc (DPZ)
Bought 2 shares at $395.84/share.
Enterprise Products (EPD)
Bought 50 shares at $21.59/share.
Freeport-McMoran Inc (FCX)
Bought 10 shares at $34.90/share.
Generac Holdings Inc (GNRC)
Bought 1 share at $314.87/share.
LVMH Moet Hennessy (LVMUY)
Bought 5 shares at $131.51/share.
The Estee Lauder Companies Inc (EL)
Bought 3 shares at $292.75/share.
Stitch Fix Inc (SFIX)
Bought 10 shares at $48/share.
Square Inc (SQ)
Bought 1 share at $253.
Shopify Inc (SHOP)
Bought 1 share at $1,495.
Bought 1 share at $692.
As always you can always visit my portfolio page to see all the securities I hold.
Random Useless Fact:
CAPTCHA tests are getting harder these days.